Canada Pension Plan Investment Board’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $690K | Sell |
4,000
-1,500
| -27% | -$278K | ﹤0.01% | 1119 |
|
|
2025
Q4 | $1.1M | Sell |
5,500
-98,300
| -95% | -$17.8M | ﹤0.01% | 1048 |
|
|
2025
Q3 | $16.2M | Sell |
103,800
-1,200
| -1% | -$191K | 0.01% | 527 |
|
|
2025
Q2 | $15.9M | Sell |
105,000
-300
| -0.3% | -$40K | 0.01% | 509 |
|
|
2025
Q1 | $15.8M | Buy |
105,300
+102,000
| +3,091% | +$17.1M | 0.02% | 495 |
|
|
2024
Q4 | $609K | Buy |
+3,300
| New | +$636K | ﹤0.01% | 1072 |
|
|
2024
Q3 | – | Sell |
-600
| Closed | -$124K | – | 1358 |
|
|
2024
Q2 | $124K | Buy |
+600
| New | +$136K | ﹤0.01% | 1160 |
|
|
2023
Q1 | – | Sell |
-533
| Closed | -$116K | – | 1092 |
|
|
2022
Q4 | $116K | Buy |
533
+500
| +1,515% | +$109K | ﹤0.01% | 1015 |
|
|
2022
Q3 | $7K | Sell |
33
-2,000
| -98% | -$432K | ﹤0.01% | 1171 |
|
|
2022
Q2 | $435K | Buy |
2,033
+1,300
| +177% | +$318K | ﹤0.01% | 977 |
|
|
2022
Q1 | $208K | Buy |
+733
| New | +$226K | ﹤0.01% | 1095 |
|
|
2021
Q4 | – | Sell |
-389
| Closed | -$160K | – | 1472 |
|
|
2021
Q3 | $160K | Sell |
389
-357
| -48% | -$148K | ﹤0.01% | 1229 |
|
|
2021
Q2 | $276K | Buy |
+746
| New | +$249K | ﹤0.01% | 931 |
|
|
2020
Q3 | – | Sell |
-9,126
| Closed | -$1.59M | – | 1161 |
|
|
2020
Q2 | $1.59M | Buy |
+9,126
| New | +$1.46M | ﹤0.01% | 798 |
|
|
2019
Q1 | – | Sell |
-32,100
| Closed | -$3.63M | – | 1554 |
|
|
2018
Q4 | $3.63M | Hold |
32,100
| – | – | 0.01% | 854 |
|
|
2018
Q3 | $4.32M | Sell |
32,100
-124,900
| -80% | -$15.4M | 0.01% | 857 |
|
|
2018
Q2 | $17.6M | Sell |
157,000
-50,200
| -24% | -$5.43M | 0.03% | 415 |
|
|
2018
Q1 | $22.1M | Buy |
207,200
+11,400
| +6% | +$1.23M | 0.04% | 371 |
|
|
2017
Q4 | $21.4M | Buy |
195,800
+185,100
| +1,730% | +$20.1M | 0.04% | 351 |
|
|
2017
Q3 | $1.16M | Sell |
10,700
-3,600
| -25% | -$370K | ﹤0.01% | 931 |
|
|
2017
Q2 | $1.45M | Buy |
14,300
+1,500
| +12% | +$138K | ﹤0.01% | 877 |
|
|
2017
Q1 | $1.15M | Buy |
12,800
+5,500
| +75% | +$467K | ﹤0.01% | 877 |
|
|
2016
Q4 | $556K | Buy |
7,300
+3,700
| +103% | +$281K | ﹤0.01% | 842 |
|
|
2016
Q3 | $300K | Sell |
3,600
-600
| -14% | -$50.3K | ﹤0.01% | 920 |
|
|
2016
Q2 | $346K | Sell |
4,200
-900
| -18% | -$74.1K | ﹤0.01% | 919 |
|
|
2016
Q1 | $387K | Buy |
5,100
+200
| +4% | +$14.8K | ﹤0.01% | 946 |
|
|
2015
Q4 | $394K | Sell |
4,900
-2,000
| -29% | -$144K | ﹤0.01% | 938 |
|
|
2015
Q3 | $438K | Buy |
6,900
+300
| +5% | +$21.5K | ﹤0.01% | 958 |
|
|
2015
Q2 | $464K | Buy |
6,600
+2,400
| +57% | +$178K | ﹤0.01% | 955 |
|
|
2015
Q1 | $333K | Buy |
+4,200
| New | +$310K | ﹤0.01% | 992 |
|
|
2014
Q3 | – | Sell |
-140,000
| Closed | -$7.49M | – | 1251 |
|
|
2014
Q2 | $7.49M | Hold |
140,000
| – | – | 0.03% | 534 |
|
|
2014
Q1 | $8.45M | Buy |
140,000
+38,700
| +38% | +$2.26M | 0.03% | 478 |
|
|
2013
Q4 | $5.37M | Buy |
+101,300
| New | +$5.09M | 0.02% | 570 |
|
Other funds holding CRL
VCM
VPM
Canada Pension Plan Investment Board's CRL Position: Q1 2026 in Review
Canada Pension Plan Investment Board reduced its Charles River Laboratories (CRL) stake by 27% in Q1 2026, selling an estimated $278K and leaving 4,000 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1119.
Canada Pension Plan Investment Board first reported a position in CRL in Q4 2013 and has held it in 33 quarters since. The position peaked at $22.1M in Q1 2018. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Canada Pension Plan Investment Board held 4,000 shares of Charles River Laboratories worth $690K as of Q1 2026.
- Canada Pension Plan Investment Board sold 1,500 Charles River Laboratories shares in Q1 2026, an estimated $278K.
- Charles River Laboratories made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1119 holding.
- Canada Pension Plan Investment Board first reported a position in Charles River Laboratories in Q4 2013 and has held it in 33 quarters since.
- Canada Pension Plan Investment Board's Charles River Laboratories position peaked at $22.1M in Q1 2018.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.